NCT01098578

Floseal Treatment for Posterior Epistaxis Study

Floseal Posterior Epistaxis Pilot Study (PEPIS)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Ottawa Hospital Research Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Effectiveness of Floseal for the treatment of posterior epistaxis.

Detailed description

Floseal, a hemostatic agent, is an effective treatment for anterior epistaxis as well as numerous other acute bleeding conditions throughout the body. The investigators hypothesize that Floseal is an effective treatment for posterior epistaxis. If so, then this will also lead to significant cost savings in comparison to any other method of treatment of posterior epistaxis. The investigators have planned a prospective, nonblinded, nonrandomised study with a total of 40 subjects with posterior epistaxis to be included in this study.

Conditions

• Epistaxis

Interventions

Type	Name	Description
DRUG	Floseal	Received 1 syringe of Floseal as treatment for posterior epistaxis.

Timeline

• Start date: 2010-04-01
• Primary completion: 2011-11-01
• Completion: 2011-11-01
• First posted: 2010-04-02
• Last updated: 2015-01-26
• Results posted: 2015-01-26